Mechanisms of acute and chronic hypoglycemic action of gliclazide

Acta Diabetologica

Volumn 37, Issue 4, 2000, Pages 201-206

  Da Tos, V ^a   Maran, A ^a   Vigili de Kreutzenberg, S ^a   Marchetto, S ^a   Tadiotto, F ^a   Bettio, M ^a   Marescotti, M C ^a   Tiengo, A ^a   Del Prato, S ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b CISANELLO HOSPITAL   (Italy)

Author keywords

Endogenous glucose production; Gliclazide; Glucose kinetics; Glucose tolerance; Insulin secretion; Sulfonylurea

Indexed keywords

C PEPTIDE; GLICLAZIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; PLACEBO; SULFONYLUREA;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ACUTE DISEASE; BLOOD GLUCOSE; C-PEPTIDE; CHRONIC DISEASE; DIABETES MELLITUS, TYPE 2; GLICLAZIDE; GLUCONEOGENESIS; GLUCOSE CLAMP TECHNIQUE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; KINETICS; MIDDLE AGED; PLACEBOS; REGRESSION ANALYSIS; TIME FACTORS; TRITIUM;

EID: 0034438048     PISSN: 09405429     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005920070006     Document Type: Article

References (17)

1. Sulfonylureas in NIDDM
2. Oral hypoglycemic agents
3. Mechanism of improvement in glucose metabolism after chronic glyburide therapy
4. The impact of sulfonylureas on hepatic glucose metabolism in type II diabetics
5. Hepatic sensitivity to insulin. Effects of sulfonylurea drugs
6. Glucose toxicity
7. Gliclazide potentiates suppression of hepatic glucose production in non-insulin dependent diabetic patients
8. Glucose kinetics
9. Estimation of endogenous glucose production during hyperinsulinemic glucose clamps: Comparison of unlabelled and labelled exogenous glucose infusates
10. The mode of action and clinical pharmacology of gliclazide: A review
11. The effects of ingestion time of gliclazide in relationship to meals on plasma glucose, insulin and C-peptide levels
12. Effect of glyburide on glycaemic control, insulin requirement and glucose metabolism in insulin-treated diabetic patients
13. The impact of sulfonylurea treatment upon the mechanisms responsible for the insulin resistance in type II diabetes
14. Gliclazide therapy is associated with potentiation of postbinding insulin action in obese, non-insulin-dependent diabetic subjects
15. Sulfonylurea therapy improves glucose disposal without changing skeletal muscle GLUT4 levels in noninsulin-dependent diabetes mellitus subjects: A longitudinal study
16. Lilly lecture 1987. The triumvirate: Beta-cell, muscle, liver. A collusion responsible for NIDDM
17. The disposal of an oral glucose load in patients with noninsulin-dependent diabetes